Safety and efficacy study of Lutein (VitaLutein®) in healthy Japanese adults: A randomized, placebo-controlled, double-blind, parallel-group comparative study
DOI:
https://doi.org/10.31989/ffhd.v15i5.1605Abstract
Background: Lutein is a natural pigment with antioxidant properties found in both the eye's lens and macula. Daily exposure to certain wavelengths of light -- particularly blue and infrared – can increase the eyes' vulnerability to oxidative damage caused by free radicals. However, lutein’s antioxidant properties help protect cells from oxidative damage.
Objective: This study aimed to evaluate the reduction of oxidative stress in tears resulting from daily intake of VitaLutein®, within healthy Japanese adults. The safety of oral VitaLutein® intake was also assessed.
Methods: A randomized, placebo-controlled, double-blind, parallel-group study was conducted. Thirty-one healthy Japanese adults were randomized to either the placebo or VitaLutein® group. Participants were enrolled based on levels of 8-hydroxydeoxyguanosine (8-OHdG) in their tears. Fifteen adults were assigned to the VitaLutein® group and sixteen to the placebo group. After 8-weeks, all subjects were evaluated for oxidative stress, macular pigment optical density, and dry eye symptoms. Safety assessments included urinalysis and blood tests.
Results: No adverse events were attributed to the test food during the study period. Levels of 8-OHdG were significantly reduced at week 8 compared to baseline in the VitaLutein® group. Additionally, participants with prolonged Visual Display Terminal (VDT) use maintained higher Macular Pigment Optical Density (MPOD) levels compared to the placebo group.
Novelty: This randomized controlled trial uniquely demonstrates the safety of VitaLutein® supplementation in healthy Japanese adults. This study provides preliminary evidence suggesting its potential to reduce tear oxidative stress (8-OHdG) and maintain macular pigment optical density (MPOD), particularly in individuals with prolonged extended VDT usage.
Conclusions: These results suggest that continuous ingestion of VitaLutein® supplements may reduce oxidative stress and maintain macular pigment. The product has also been proven safe in adult, human subjects.
Keywords: VitaLutein®, Oxidative Stress, 8-hydroxy-2-deoxyguanosine(8-OHdG), Visual Display Terminal (VDT), macular pigment density (MPOD).(UMIN ID: UMIN000014590)
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Functional Foods in Health and Disease
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Any manuscripts or substantial parts of it, submitted to the journal must not be under consideration by or previously published in any other journal or citable form. Authors are required to ensure that no material submitted as part of a manuscript infringes existing copyrights or the rights of a third party. In submitting one's article in any form, the author has assigned the FFC publishing rights and has agreed to an automatic transfer of the copyright to the publisher. This is so that the FFC may create print option journals, for example, at the FFC’s discretion. If the author wishes to distribute their works by means outside of the FFC, for example within their community, they will have to place a request.
Correspondence concerning articles published in Functional Foods in Health and Disease is encouraged. While derivative works (adaptations, extensions on the current work, etc.) are allowed, distribution of the modified material is not allowed without permission from the FFC.